Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Sotio Biotech Inc.
Sotio Biotech Inc.
Pfizer
Pfizer
National Institutes of Health Clinical Center (CC)
Novartis
Ocellaris Pharma, Inc.
Gustave Roussy, Cancer Campus, Grand Paris
Bolt Biotherapeutics, Inc.
HiFiBiO Therapeutics
Incyte Corporation
Actym Therapeutics, Inc.
Pfizer
Pfizer
NuCana plc
NRG Oncology
Pfizer
Kymab Limited
Incyte Corporation
Incyte Corporation
Molecular Templates, Inc.
Inhibrx Biosciences, Inc
Novartis
Pfizer
Hoffmann-La Roche
Pfizer
ADC Therapeutics S.A.
Pfizer
Ikena Oncology
HiberCell, Inc.
University of Florida
Fate Therapeutics
Fate Therapeutics
Hoffmann-La Roche
Genmab
City of Hope Medical Center
Nektar Therapeutics
Gossamer Bio Inc.
Genocea Biosciences, Inc.
Apollomics (Australia) Pty. Ltd.
Calithera Biosciences, Inc
MacroGenics
Incyte Corporation
Cambridge University Hospitals NHS Foundation Trust
Seagen Inc.
Yale University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
AbbVie
Mayo Clinic
Western Regional Medical Center
Masonic Cancer Center, University of Minnesota